Opendata, web and dolomites

IMPLANTaLive SIGNED

Explore the potentialities of living implants for medical devices

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IMPLANTaLive project word cloud

Explore the words cloud of the IMPLANTaLive project. It provides you a very rough idea of what is the project "IMPLANTaLive" about.

disrupting    public    releasing    living    tissue    implant    injured    attractive    surfaces    reactions    infections    inferior    healthy    mostly    suitably    performance    reconstruction    loops    site    conditioning    responsive    ligament    industry    status    coating    approved    easily    financing    interacting    health    technologies    fda    science    market    vivo    patient    bacteria    combined    gras    disturbs    function    host    membrane    adhesion    suitable    feedback    majority    cell    cellular    introduction    quality    implantalive    stimulate    societal    surface    fail    inherently    vascular    stimuli    opportunity    express    tendon    companies    biocoatings    proteins    poor    metal    routes    provides    implantation    causing    economic    medical    adverse    pathogenic    biological    body    restoring    advantages    coatings    leave    dynamic    innovative    sick    enhances    business    repair    conventional    static    polymeric    surroundings    ie    caused    actively    influence    hence    bidirectionality    endothelial    expressed    proper    dynamics    markets    bound    offers    biocoating    cells   

Project "IMPLANTaLive" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT TWENTE 

Organization address
address: DRIENERLOLAAN 5
city: ENSCHEDE
postcode: 7522 NB
website: www.utwente.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-04-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT TWENTE NL (ENSCHEDE) coordinator 150˙000.00

Map

 Project objective

IMPLANTaLive coating technology provides an exciting business opportunity. IMPLANTaLive offers unique advantages of societal and economic importance such as public health and sick leave.

Living, dynamic coatings for medical devices, ie. coatings with proper cell response upon implantation, are attractive for restoring body function. Conventional implant coatings are of inferior quality and therefore the majority, if not all, biocoatings fail in suitably interacting with host tissue. This poor performance of existing biocoating technologies is mostly caused by inherently static properties of surface coating, which disturbs the inherently dynamics between cells and surroundings, disrupting healthy tissue response and eventually causing adverse reactions like infections. Living coatings are produced by an innovative one step pre-conditioning of FDA approved polymeric and metal surfaces. Living non-pathogenic bacteria with GRAS status are suitable for in-vivo use, which provide medical devices with dynamic and responsive characteristics.

Dynamic IMPLANTaLive coatings provide bidirectionality, ie. the ability to process biological stimuli by cellular control feedback loops and hence influence cellular and tissue characteristics and responses. This greatly enhances the application potential as the living coating can be easily tailored to the specific needs of a patient. IMPLANTaLive coatings can actively stimulate the reconstruction or injured site by releasing specific growth factors (relevant for ligament and tendon repair) or express membrane bound endothelial cell specific adhesion proteins (relevant for vascular devices).

A business case will be developed for IMPLANTaLive covering different markets and routes for market introduction. Results of market analysis and financing needs will be combined with science-based technology comparison and used for discussions with potential industry partners. Several companies have already expressed interest in IMPLANTaLive.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPLANTALIVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMPLANTALIVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

GelGeneCircuit (2020)

Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits.

Read More  

MATCH (2020)

Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research

Read More